fbpx
QQQ
+ 0.00
326.39
+ 0%
DIA
+ 0.00
344.23
+ 0%
SPY
+ 0.00
416.49
+ 0%
TLT
+ 0.00
137.08
+ 0%
GLD
+ 0.00
172.69
+ 0%

Cannabis Sales Expected To Hit $370M In 5 Days Leading Up To 420

April 13, 2021 2:10 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Cannabis Sales Expected To Hit $370M In 5 Days Leading Up To 420

Cannabis software firm Akerna Corp (NASDAQ:KERN) expects national cannabis retail sales to reach $95 million on 4/20, the unofficial marijuana holiday.

That is according to a new Flash Report out of the Denver-based company.

Flower Power

Akerna says the top-selling product category on Tuesday, April 20, will be flower, accounting for 49% of all legal sales. To put this into perspective: flower has claimed 45% of all legal cannabis sales daily in 2021.

Vape pens and cartridges will be the second most popular product among the customers on 4/20, the firm anticipates.

In addition, concentrates and infused edibles are expected to account for 11% and 8% of all cannabis sales, respectively.

The average order total will be roughly $10 higher than usual, with each customer spending $105 on average, versus the $93.48 2021 average.

Related content: Benzinga's Full Retail Sales Calendar

Furthermore, customers are poised to purchase an average of 3.69 products. The average basket in 2021 so far has carried 2.83 products.

According to the company's report, sales will be higher among male than female, while customers aged between 30 and 40 will be the most interested in purchasing cannabis products.

The report suggests that the five days ending April 20 are expected to yield $370 million in cannabis sales.

"Elevated sales mean traffic will be at a high, making it critical for retailers to prepare their inventory, staff, and space for these upticks," concluded James Ahrendt, business intelligence architect at Akerna.

Photo by Steven Foster on Unsplash


Related Articles

Akerna: 420 2021 Set Single-Day Record For Cannabis Sales

The April 20 cannabis holiday brought $111.8 million in medical and recreational sales in 2021, according to a new report Wednesday from cannabis software firm Akerna Corp (NASDAQ: KERN).  read more

Cannabis Software Firms Akerna, Viridian Sciences Agree To All-Stock Deal

Akerna Corp (NASDAQ: KERN) has agreed to acquire fellow cannabis business software firm Viridian Sciences in an all-stock transaction.  The terms of the deal were not disclosed. read more

Earnings Update: GRWG Hits Record Revenue, Charlotte's Web Cites EBITDA Losses, Akerna Software Revenue Spikes

GrowGeneration Hits Record Revenue, Raises Revenue Guidance read more

Akerna's MJ Freeway Wins All Of Iowa Medical Cannabis Dispensary Licenses

Akerna (NASDAQ: KERN) confirmed Thursday that two of its MJ Freeway consulting clients obtained the only two medical cannabis dispensary licenses in Iowa. read more